Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 3/20 | 0.36 |
| ▸ | F2 | P00734 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22667665 | 0.94 | HTT (0.45) | TSHRHPGDHTTKMT2ASMN1; SMN2 | |
| SCHEMBL22667667 | 0.94 | HTT (0.45) | TSHRHPGDHTTKMT2ASMN1; SMN2 | |
| SCHEMBL24595939 | 0.91 | SMN1; SMN2 (0.40) | TSHRHPGDHTTKMT2ASMN1; SMN2 | |
| SCHEMBL22700804 | 0.90 | THRB (0.45) | TSHRHPGDHTTKMT2ASMN1; SMN2 | |
| SCHEMBL22667663 | 0.89 | TSHR (0.42) | TSHRHPGDHTTKMT2ASMN1; SMN2 | |
| SCHEMBL24196278 | 0.88 | THRB (0.49) | TSHRHPGDHTTKMT2ASMN1; SMN2 | |
| SCHEMBL13289875 | 0.88 | NAAA (0.41) | TSHRHPGDHTTKMT2ASMN1; SMN2 | |
| SCHEMBL22667423 | 0.88 | ELANE (0.42) | TSHRHPGDHTTKMT2ASMN1; SMN2 | |
| SCHEMBL19978546 | 0.87 | HTT (0.45) | TSHRHPGDHTTKMT2ASMN1; SMN2 | |
| SCHEMBL24196576 | 0.87 | ELANE (0.44) | TSHRHPGDHTTKMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220214484-A1 | OPTICALLY ANISOTROPIC LAYER, OPTICAL FILM, POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2022-07-07 | — | — | US | disclosed |
| US-20090274853-A1 | DICHROIC DYE COMPOSITION | FUJIFILM CORPORATION (JP) | 2009-11-05 | — | — | US | disclosed |
| US-20090274853-A1 | DICHROIC DYE COMPOSITION | FUJIFILM CORPORATION (JP) | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090274853-A1 | DICHROIC DYE COMPOSITION | C1S, CDY1; CDY1B, CRY1 | TSHR 2259/4885HPGD 2896/4885HTT 1918/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.